M&A Deal Summary |
|
|---|---|
| Date | 2012-08-15 |
| Target | Beijing BioOne Medical Technology Co. |
| Sector | Medical Products |
| Buyer(s) | MEDINET Co. |
| Sellers(s) | Bio-One |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1995 |
| Sector | Life Science |
| Employees | 92 |
| Revenue | 769M JPY (2024) |
MEDINET is a cell therapy supporting medical service providers. Through its service, Medinet provides medical institutions with advanced technologies and know-how in cell processing and culturing, quality control, and facility management with respect to immuno-cell therapy. MEDINET was founded in 1995 and is based in Tokyo, Japan.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: China M&A | 1 of 1 |
| Year: 2012 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-09-14 |
Lymphotec
Tokyo, Japan Lymphotec, Inc. is a biotech company which provides medical supporting service and sells reagents with related to Activated Lymphocyte Therapies to medical institutions. |
Buy | - |
Bio-One Corp. is a holding company operating through its subsidiaries that manufactures, markets, and distributes nutritional supplements in the United States.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: China M&A | 1 of 1 |
| Year: 2012 M&A | 1 of 1 |
